SCHEMBL926378

SCHEMBL926378

CC1CCC(C(C)C)C(C(=O)Nc2ccc3ncsc3c2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.58
DYRK3 O43781 1/20 0.46
CLK1 P49759 1/20 0.46
CLK2 P49760 1/20 0.46
CLK3 P49761 1/20 0.46
DYRK1A Q13627 1/20 0.46
DYRK2 Q92630 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
DYRK4 Q9NR20 1/20 0.46
DYRK1B Q9Y463 1/20 0.46
CHRM5 P08912 2/20 0.44
UBE2M P61081 1/20 0.42
DCUN1D1 Q96GG9 1/20 0.42
IKBKB O14920 1/20 0.42
CHUK O15111 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4D Q08499 1/20 0.42
IRAK4 Q9NWZ3 4/20 0.41
CHKA P35790 1/20 0.41
CHKB Q9Y259 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL926043 0.80 TRPM8 (0.57) TRPM8IRAK4EPHX1NPC1RAB9A
SCHEMBL2628739 0.78 TRPM8 (0.67) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL14565718 0.78 TRPM8 (0.67) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL2628764 0.78 TRPM8 (0.65) TRPM8EPHX1MEN1KMT2A
SCHEMBL15133466 0.78 TRPM8 (0.62) TRPM8EPHX1NPC1RAB9A
SCHEMBL2628672 0.77 TRPM8 (0.75) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL4817319 0.77 TRPM8 (0.75) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL10073486 0.77 TRPM8 (0.75) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL4820732 0.77 TRPM8 (0.75) TRPM8EPHX1MEN1NPC1RAB9A
SCHEMBL5448215 0.77 TRPM8 (0.64) TRPM8EPHX1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868004-B2 Menthane carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2011-01-11 US disclosed
EP-1853565-B1 MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2010-09-22 EP disclosed
US-20080305051-A1 Menthane Carboxamide Derivatives Having Cooling Properties GIVAUDAN S.A. (CH) 2008-12-11 US disclosed
EP-1853565-A1 MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2007-11-14 EP disclosed
WO-2006092074-A1 MENTHANE CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2006-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080305051-A1 Menthane Carboxamide Derivatives Having Cooling Properties MDH2, ME2, H1-0 TRPM8 72/4885DYRK3 192/4885CLK1 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.